In general you're right about trips, but I believe the

New Post Public Reply Private Reply Replies (0) Message Board
mdimport Desert_Dog #267
In general you're right about trips, but I believe the issue is more complex. Investors need to see:

- the CEO performing. The bashers on iHub undertook a massive character assassination job on Matt Dwyer and BCAP....

- the business plan being executed without massive dilution. The result here is mixed - TA up and running, name change occurred, but we had an A/S and O/S increase...

- revenue generation and then profit. A/S and O/S increase was to accelerate revenue growth by funding $RIGH and $TGGI. It's hard to explain over and over when the CEO's character is being assassinated....


Question is even if BCAP trades in the 00's, how does it undo the damage to investor confidence caused when BCAP traded in the trips?


The best thing Matt can do right now IMO is acquire a slightly smaller brokerage that will not require dilution and file for the additional licenses post factum. There are time delays with this because of the approval process, but it will kill the dilution argument. It's really a question of balance and strategy.

Baron Capital Enterprise, INC. (BCAP) Stock Research Links

BCAP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Unlocking Revolutionary Golf Insights with XView AI for All Levels

Updated Category News Views 1046

Revolutionizing Golf Swing Analysis with XView AI In an exciting advancement for golfers everywhere, IdeasLab has unveiled XView AI, an innovative markerless app designed to deliver comprehensive golf swing analysis in real time. This app, endorsed by renowned PGA Tour Champion K.J. Choi and celebrated coach Pete Buchanan, presents an accessible solution for coaches,...

Continue Reading
Ultragenyx Pharmaceutical Under Scrutiny: Investor Investigation Ongoing

Updated Category News Views 255

Investigation into Ultragenyx Pharmaceutical Inc. Pomerantz LLP has initiated an inquiry into potential claims for investors of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE). The firm is reaching out to investors for feedback and insights amidst concerns of possible unlawful practices involving the company's management. Concerns of Unlawful Business Practices The...

Continue Reading
Arras Minerals Set to Shine at Upcoming Minerals Investor Event

Updated Category News Views 135

Arras Minerals Invites Investors to Join Virtual Conference Arras Minerals Corp (TSXV: ARK, OTCQB: ARRKF) from Vancouver, Canada, has made a significant announcement about its upcoming participation in a virtual conference focusing on precious and critical minerals. This event is particularly important for those interested in exploring investment opportunities in...

Continue Reading
Unlocking New Income Streams with PBK Miner’s Cloud Mining

Updated Category News Views 302

Revolutionizing Mining: The Future of XRP Income The innovative approach to XRP mining through cloud contracts is starting to resonate with investors, particularly as XRP faces resistance around the $2.4 mark. Recent developments have shown that while XRP has struggled, innovative platforms like PBK Miner provide opportunities for passive income generation for crypto...

Continue Reading
Modine's Strategic Acquisition of L.B. White: Market Expansion

Updated Category News Views 318

Modine's Acquisition of L.B. White to Enhance Heating Technology Modine, a global leader in thermal management technologies, recently made headlines by announcing its acquisition of L.B. White, a prominent provider of specialized heating solutions. This strategic move not only diversifies Modine’s portfolio but also strengthens its position in the HVAC industry. By...

Continue Reading